JUN 05, 2018 09:45 PM PDT

Precision vs. Personalized Medicine Part I: Precision Approach

WRITTEN BY: Mauri Brueggeman
3 6 333

Are you hearing a lot about personalized medicine these days?  What about precision medicine? It seems like the information being discussed is not necessarily new.  Why does it seem to be everywhere lately?  There are many answers to that but this two part series aims to outline some of the features of these models of medicine as a foundation.

Precision medicine is defined as a model for medicine that is customized based on the individual patient; all aspects of care can be personalized including medical decisions, treatments, practices, and products or services used.  Another similar sounding term is “personalized medicine”.  That National Institutes of Health indicates that there is overlap in the two terms.  The real difference is mostly in the interpretation of the word “personalized” as compared to “precision”. 

Precision, as a single word, means to hit a target in the same place over and over.  Precision medicine aims to create medicine models that target a similar feature of a disease that appears in multiple diseases or cancers in some cases.  This model is not unique for one single individual, however.  This approach aims to identify which approaches will be effective for patients based on genetic, environmental, and lifestyle aspects. 

The changes in technology and knowledge acquisition over the past few decades allow clinicians and researchers access to heaps of data on different cancer types.  The historical approach has been to lump the cancer types together and treat everyone with that cancer type in the same therapeutic manner.  Yet there are patients that do not respond to that therapy at all despite having the pathology/morphology of one type of cancer.  We now know that there are molecular factors at play, right down to our DNA, which affect how a treatment may work on those cancerous cells.  If the treatment action is based on one pathway leading to disease, what happens when that disease occurs due to a different pathway malfunction?  Precision medicine dumps into the field of computational oncology which employs the expertise of statisticians, mathematicians, physicists, computer scientists, cancer biologists, physiological experts, physicians, researchers, and many more to create data programs and models including genetic profiles and therapeutic approaches for different cancers.  In addition, pharmacogenetics is part of precision medicine because the whole basis of this field of study is how gene’s affect a particular patient’s response to a given pharmaceutical agent.  If you enjoy pharmacology and genomics, this is the field for you.

The National Research Council has documented that they prefer the term precision medicine; the work involves building a network for biomedical research in order to basically develop a new taxonomical structure for disease.  The National Academy of Sciences, in collaboration with the National Academy of Engineering, the Institute of Medicine, and the National Research Council, published a report exploring the future of precision medicine in 2011. 

Sources: NIH – U.S. National Library of Medicine, National Academies Press – National Research Council,  Journal for Biomedical Informatics, Annals of Gastroenterology & Surgery,

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAY 02, 2018
Cancer
MAY 02, 2018
Low Muscle Mass Could Be Affecting Breast Cancer Survival
Breast cancer patients that have low muscle mass were shown in a recent study to have higher mortality than patients with higher muscle mass at the time of diagnosis.
MAY 28, 2018
Cancer
MAY 28, 2018
Wilms Tumor Clinical Trial Combined Chemo Treatment Results in Reduced Use of Radiotherapy for Lung Metastases
Wilms tumors occur in young children and treatment for lung metastases has included radiotherapy. A Phase III Clinical Trial evaluated combination chemotherapy and reduction or omission of r
JUN 20, 2018
Cancer
JUN 20, 2018
Peruvian Plant's Unique Anti-Tumor Biological Mechanism Discovered
Plagiochiline A is a molecule that exhibits antiproliferative properties and is cytotoxic. New research outlines the unique biological mechanism valued as possible cancer therapy target.
JUL 17, 2018
Cancer
JUL 17, 2018
Immunotherapy Diversification: From CAR-T cells to CAR-NK cells
New advances have made it possible for immunotherapy researchers to use natural killer cells, which are our body's normal defense for cancerous cells, to target tumors.
JUL 24, 2018
Cancer
JUL 24, 2018
Transfection, Transduction, and CRISPR...Oh My
CRISPR gene editing came about based on transfection and transduction type models of genetic transfer. There is potential for it to revolutionize gene editing but are there dangers lurking?
AUG 02, 2018
Genetics & Genomics
AUG 02, 2018
The Genetic Hotspots That Can Lead to Cancer
In some of our body's tissues, cells have to replicate many times. That introduces a chance for new genetic errors every time.
Loading Comments...